{"filing":{"accession_number":"0001104659-26-089725","cik":"0001333141","ticker":"FMCQF","company_name":"Fresenius Medical Care AG","form":"6-K","filing_date":"2026-08-03","report_date":"2026-08-03","primary_document":"tm2622055d2_6k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1333141/000110465926089725/tm2622055d2_6k.htm"},"events":[{"id":23066,"run_id":20882,"accession_number":"0001104659-26-089725","anchor_item_number":"EX-99.1","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"This exhibit discloses Fresenius Medical Care's Q2 2026 financial results, reporting operating income excluding special items of EUR 569 million (up 23% at constant currency) and group revenue of EUR 4,861 million (up 4% at constant currency), both exceeding market consensus expectations. The company also confirms its full-year 2026 outlook. This is a discrete earnings announcement for a quarterly period, material to investors assessing the registrant's financial performance.","company_name":"Fresenius Medical Care AG","ticker":"FMCQF","filing_date":"2026-08-03","form":"6-K","submitted_at":null,"items":[{"id":23207,"accession_number":"0001104659-26-089725","item_number":"EX-99.1","item_title":"tm2622055d2_ex99-1.htm","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This exhibit discloses Fresenius Medical Care's Q2 2026 financial results, reporting operating income excluding special items of EUR 569 million (up 23% at constant currency) and group revenue of EUR 4,861 million (up 4% at constant currency), both exceeding market consensus expectations. The company also confirms its full-year 2026 outlook. This is a discrete earnings announcement for a quarterly period, material to investors assessing the registrant's financial performance.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-04T00:26:29.704569+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":23207,"accession_number":"0001104659-26-089725","item_number":"EX-99.1","item_title":"tm2622055d2_ex99-1.htm","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This exhibit discloses Fresenius Medical Care's Q2 2026 financial results, reporting operating income excluding special items of EUR 569 million (up 23% at constant currency) and group revenue of EUR 4,861 million (up 4% at constant currency), both exceeding market consensus expectations. The company also confirms its full-year 2026 outlook. This is a discrete earnings announcement for a quarterly period, material to investors assessing the registrant's financial performance.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-04T00:26:29.704569+00:00","company_name":"Fresenius Medical Care AG","ticker":"FMCQF","filing_date":"2026-08-03"}]}